Biotechnology Halozyme to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference June 8, 2022
Biotechnology Allogene Therapeutics Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to ALLO-501A for Large B Cell Lymphoma June 8, 2022